CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancer
María Rodrigo‐Faus, Inés del Monte-García, Marina Hermosilla-Trespaderne, Alicia Gordo-Vega, Natália Vidal, Javier Puente, Melchor Saiz‐Pardo, Ángel M. Cuesta, Hui‐Qi Qu, Hakon H. Hakonarson, Almudena Porrás, Daniel Sanchez Parcerisa, Paloma Bragado, Álvaro Gutiérrez-Uzquiza
This study identifies SYCP3 as a driver of prostate cancer metastasis through CRISPR screening and shows its role in invasion, adhesion, and radiotherapy resistance.
bioRxiv · Jan 30, 2025 · PreprintCancer Biology